[Recent topics on important drugs for H. pylori eradication: Minocycline (MINO)].
Nishino
Takeshi
T
Kyoto Pharmaceutical University.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008911:Minocycline / Q000008:administration & dosage* / Q000494:pharmacology*; D012269:Ribosomal Proteins / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012269:Ribosomal Proteins; C040469:ribosomal protein S30; D008911:Minocycline